These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21674534)

  • 1. Liquid formulation of pentoxifylline is a poorly tolerated treatment for duchenne dystrophy.
    Zimmerman A; Clemens PR; Tesi-Rocha C; Connolly A; Iannaccone ST; Kuntz N; Arrieta A; Hache L; Henricson E; Hu F; Mayhew J; Escolar DM
    Muscle Nerve; 2011 Aug; 44(2):170-3. PubMed ID: 21674534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline as a rescue treatment for DMD: a randomized double-blind clinical trial.
    Escolar DM; Zimmerman A; Bertorini T; Clemens PR; Connolly AM; Mesa L; Gorni K; Kornberg A; Kolski H; Kuntz N; Nevo Y; Tesi-Rocha C; Nagaraju K; Rayavarapu S; Hache LP; Mayhew JE; Florence J; Hu F; Arrieta A; Henricson E; Leshner RT; Mah JK
    Neurology; 2012 Mar; 78(12):904-13. PubMed ID: 22402864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial.
    Mah JK; Clemens PR; Guglieri M; Smith EC; Finkel RS; Tulinius M; Nevo Y; Ryan MM; Webster R; Castro D; Kuntz NL; McDonald CM; Damsker JM; Schwartz BD; Mengle-Gaw LJ; Jackowski S; Stimpson G; Ridout DA; Ayyar-Gupta V; Baranello G; Manzur AY; Muntoni F; Gordish-Dressman H; Leinonen M; Ward LM; Hoffman EP; Dang UJ;
    JAMA Netw Open; 2022 Jan; 5(1):e2144178. PubMed ID: 35076703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
    Smith EC; Conklin LS; Hoffman EP; Clemens PR; Mah JK; Finkel RS; Guglieri M; Tulinius M; Nevo Y; Ryan MM; Webster R; Castro D; Kuntz NL; Kerchner L; Morgenroth LP; Arrieta A; Shimony M; Jaros M; Shale P; Gordish-Dressman H; Hagerty L; Dang UJ; Damsker JM; Schwartz BD; Mengle-Gaw LJ; McDonald CM;
    PLoS Med; 2020 Sep; 17(9):e1003222. PubMed ID: 32956407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CINRG pilot trial of oxatomide in steroid-naïve Duchenne muscular dystrophy.
    Buyse GM; Goemans N; Henricson E; Jara A; van den Hauwe M; Leshner R; Florence JM; Mayhew JE; Escolar DM
    Eur J Paediatr Neurol; 2007 Nov; 11(6):337-40. PubMed ID: 17459739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy.
    Spurney CF; Rocha CT; Henricson E; Florence J; Mayhew J; Gorni K; Pasquali L; Pestronk A; Martin GR; Hu F; Nie L; Connolly AM; Escolar DM;
    Muscle Nerve; 2011 Aug; 44(2):174-8. PubMed ID: 21698649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial.
    Clemens PR; Rao VK; Connolly AM; Harper AD; Mah JK; Smith EC; McDonald CM; Zaidman CM; Morgenroth LP; Osaki H; Satou Y; Yamashita T; Hoffman EP;
    JAMA Neurol; 2020 Aug; 77(8):982-991. PubMed ID: 32453377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy.
    Escolar DM; Hache LP; Clemens PR; Cnaan A; McDonald CM; Viswanathan V; Kornberg AJ; Bertorini TE; Nevo Y; Lotze T; Pestronk A; Ryan MM; Monasterio E; Day JW; Zimmerman A; Arrieta A; Henricson E; Mayhew J; Florence J; Hu F; Connolly AM
    Neurology; 2011 Aug; 77(5):444-52. PubMed ID: 21753160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidants for Treatment of Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis.
    Ren S; Yao C; Liu Y; Feng G; Dong X; Gao B; Qian S
    Eur Neurol; 2022; 85(5):377-388. PubMed ID: 35697003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function.
    Hoffman EP; Schwartz BD; Mengle-Gaw LJ; Smith EC; Castro D; Mah JK; McDonald CM; Kuntz NL; Finkel RS; Guglieri M; Bushby K; Tulinius M; Nevo Y; Ryan MM; Webster R; Smith AL; Morgenroth LP; Arrieta A; Shimony M; Siener C; Jaros M; Shale P; McCall JM; Nagaraju K; van den Anker J; Conklin LS; Cnaan A; Gordish-Dressman H; Damsker JM; Clemens PR;
    Neurology; 2019 Sep; 93(13):e1312-e1323. PubMed ID: 31451516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy.
    Finanger E; Vandenborne K; Finkel RS; Lee Sweeney H; Tennekoon G; Yum S; Mancini M; Bista P; Nichols A; Liu H; Fretzen A; Donovan JM
    J Neuromuscul Dis; 2019; 6(1):43-54. PubMed ID: 30452422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.
    Nagy S; Hafner P; Schmidt S; Rubino-Nacht D; Schädelin S; Bieri O; Fischer D
    Trials; 2019 Nov; 20(1):637. PubMed ID: 31752977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy.
    Wood CL; Cheetham TD; Hollingsworth KG; Guglieri M; Ailins-Sahun Y; Punniyakodi S; Mayhew A; Straub V
    BMC Pediatr; 2019 Apr; 19(1):131. PubMed ID: 31023296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy.
    Previtali SC; Gidaro T; Díaz-Manera J; Zambon A; Carnesecchi S; Roux-Lombard P; Spitali P; Signorelli M; Szigyarto CA; Johansson C; Gray J; Labolle D; Porte Thomé F; Pitchforth J; Domingos J; Muntoni F
    Pharmacol Res; 2020 Sep; 159():104999. PubMed ID: 32535224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily prednisone treatment in Duchenne muscular dystrophy in southwest China.
    Hu J; Ye Y; Kong M; Hong S; Cheng L; Wang Q; Qin J; Zou L; Jiang L
    Muscle Nerve; 2015 Dec; 52(6):1001-7. PubMed ID: 25809413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures.
    Henricson EK; Abresch RT; Cnaan A; Hu F; Duong T; Arrieta A; Han J; Escolar DM; Florence JM; Clemens PR; Hoffman EP; McDonald CM;
    Muscle Nerve; 2013 Jul; 48(1):55-67. PubMed ID: 23649481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
    Griggs RC; Miller JP; Greenberg CR; Fehlings DL; Pestronk A; Mendell JR; Moxley RT; King W; Kissel JT; Cwik V; Vanasse M; Florence JM; Pandya S; Dubow JS; Meyer JM
    Neurology; 2016 Nov; 87(20):2123-2131. PubMed ID: 27566742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.
    Escolar DM; Buyse G; Henricson E; Leshner R; Florence J; Mayhew J; Tesi-Rocha C; Gorni K; Pasquali L; Patel KM; McCarter R; Huang J; Mayhew T; Bertorini T; Carlo J; Connolly AM; Clemens PR; Goemans N; Iannaccone ST; Igarashi M; Nevo Y; Pestronk A; Subramony SH; Vedanarayanan VV; Wessel H;
    Ann Neurol; 2005 Jul; 58(1):151-5. PubMed ID: 15984021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.